Published in Haematologica on May 11, 2010
ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia. J Clin Oncol (2012) 1.39
Neonatal genome-wide methylation patterns in relation to birth weight in the Norwegian Mother and Child Cohort. Am J Epidemiol (2014) 1.11
Rare allelic forms of PRDM9 associated with childhood leukemogenesis. Genome Res (2012) 1.09
Inherited genetic variation in childhood acute lymphoblastic leukemia. Blood (2015) 1.09
The Childhood Leukemia International Consortium. Cancer Epidemiol (2013) 1.09
Candidate gene association study in pediatric acute lymphoblastic leukemia evaluated by Bayesian network based Bayesian multilevel analysis of relevance. BMC Med Genomics (2012) 1.03
Genetic variants in ARID5B and CEBPE are childhood ALL susceptibility loci in Hispanics. Cancer Causes Control (2013) 0.97
Genomics of racial and ethnic disparities in childhood acute lymphoblastic leukemia. Cancer (2013) 0.96
Analysis of Patterns of Gene Expression Variation within and between Ethnic Populations in Pediatric B-ALL. Cancer Inform (2013) 0.88
ARID5B polymorphism confers an increased risk to acquire specific MLL rearrangements in early childhood leukemia. BMC Cancer (2014) 0.88
Genetic susceptibility in childhood acute leukaemias: a systematic review. Ecancermedicalscience (2015) 0.85
ARID5B and IKZF1 variants, selected demographic factors, and childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Leuk Res (2013) 0.82
Intron 3 of the ARID5B gene: a hot spot for acute lymphoblastic leukemia susceptibility. J Cancer Res Clin Oncol (2013) 0.82
Contribution of polymorphisms in IKZF1 gene to childhood acute leukemia: a meta-analysis of 33 case-control studies. PLoS One (2014) 0.81
ALG: automated genotype calling of Luminex assays. PLoS One (2011) 0.80
Confirmation of childhood acute lymphoblastic leukemia variants, ARID5B and IKZF1, and interaction with parental environmental exposures. PLoS One (2014) 0.78
Impact of promoter polymorphisms in key regulators of the intrinsic apoptosis pathway on the outcome of childhood acute lymphoblastic leukemia. Haematologica (2013) 0.78
Analysis of possible genetic risk factors contributing to development of childhood acute lymphoblastic leukaemia in the Latvian population. Arch Med Sci (2016) 0.77
Association of genetic variation in IKZF1, ARID5B, and CEBPE and surrogates for early-life infections with the risk of acute lymphoblastic leukemia in Hispanic children. Cancer Causes Control (2015) 0.77
Whole-exome sequencing of a rare case of familial childhood acute lymphoblastic leukemia reveals putative predisposing mutations in Fanconi anemia genes. BMC Cancer (2015) 0.76
Family-based exome-wide association study of childhood acute lymphoblastic leukemia among Hispanics confirms role of ARID5B in susceptibility. PLoS One (2017) 0.76
Association between CEBPE Variant and Childhood Acute Leukemia Risk: Evidence from a Meta-Analysis of 22 Studies. PLoS One (2015) 0.75
A childhood acute lymphoblastic leukemia genome-wide association study identifies novel sex-specific risk variants. Medicine (Baltimore) (2016) 0.75
Replication analysis confirms the association of several variants with acute myeloid leukemia in Chinese population. J Cancer Res Clin Oncol (2015) 0.75
Genetic susceptibility in childhood acute lymphoblastic leukemia. Med Oncol (2017) 0.75
PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet (1998) 23.25
Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet (2009) 4.47
Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet (2009) 3.71
Maximum-likelihood estimation of haplotype frequencies in nuclear families. Genet Epidemiol (2004) 2.59
ARID proteins: a diverse family of DNA binding proteins implicated in the control of cell growth, differentiation, and development. Cell Growth Differ (2002) 2.18
Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Blood (2008) 2.17
Relative efficiency of ambiguous vs. directly measured haplotype frequencies. Genet Epidemiol (2002) 1.75
Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood. Blood (2009) 1.64
Susceptibility to childhood acute lymphoblastic leukemia: influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms. Blood (1999) 1.45
ARID5B SNP rs10821936 is associated with risk of childhood acute lymphoblastic leukemia in blacks and contributes to racial differences in leukemia incidence. Leukemia (2010) 1.34
The impact of using related individuals for haplotype reconstruction in population studies. Genetics (2005) 1.31
Promoter SNPs in G1/S checkpoint regulators and their impact on the susceptibility to childhood leukemia. Blood (2006) 1.26
Molecular genetics, natural history and the demise of childhood leukaemia. Eur J Cancer (1999) 1.23
Biology and treatment of acute lymphoblastic leukemia. Pediatr Clin North Am (2008) 1.22
Repression by a differentiation-specific factor of the human cytomegalovirus enhancer. Nucleic Acids Res (1996) 1.21
Gene-gene interactions in the folate metabolic pathway influence the risk for acute lymphoblastic leukemia in children. Leuk Lymphoma (2007) 1.15
Role of NQO1, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Int J Cancer (2002) 1.05
Allelic loss in childhood acute lymphoblastic leukemia. Leuk Res (1997) 1.01
DNA repair gene XPD and XRCC1 polymorphisms and the risk of childhood acute lymphoblastic leukemia. Leuk Res (2008) 0.95
Multiplexed genotyping of ABC transporter polymorphisms with the Bioplex suspension array. Biol Proced Online (2007) 0.86
A survey of genetic and epigenetic variation affecting human gene expression. Physiol Genomics (2004) 4.99
Global patterns of cis variation in human cells revealed by high-density allelic expression analysis. Nat Genet (2009) 4.72
K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol (2012) 4.00
Allele-specific chromatin remodeling in the ZPBP2/GSDMB/ORMDL3 locus associated with the risk of asthma and autoimmune disease. Am J Hum Genet (2009) 2.56
Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk. Nat Genet (2010) 2.47
Novel associations between activating killer-cell immunoglobulin-like receptor genes and childhood leukemia. Blood (2011) 2.29
Population genomics in a disease targeted primary cell model. Genome Res (2009) 2.20
Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood (2003) 2.03
Polymorphisms in multidrug resistance-associated protein gene 4 is associated with outcome in childhood acute lymphoblastic leukemia. Blood (2009) 1.80
Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia. Genome Biol (2013) 1.57
The genes induced by signal transducer and activators of transcription (STAT)3 and STAT5 in mammary epithelial cells define the roles of these STATs in mammary development. Mol Endocrinol (2005) 1.33
Localization and role of NPC1L1 in cholesterol absorption in human intestine. J Lipid Res (2006) 1.32
Promoter SNPs in G1/S checkpoint regulators and their impact on the susceptibility to childhood leukemia. Blood (2006) 1.26
DNA variants in the dihydrofolate reductase gene and outcome in childhood ALL. Blood (2007) 1.20
Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer. J Med Genet (2006) 1.17
URI-1 is required for DNA stability in C. elegans. Development (2006) 1.16
Pediatric research and the return of individual research results. J Law Med Ethics (2011) 1.14
Parental genotypes in the risk of a complex disease. Am J Hum Genet (2002) 1.13
Role of DNA mismatch repair genetic polymorphisms in the risk of childhood acute lymphoblastic leukaemia. Br J Haematol (2003) 1.11
Rare allelic forms of PRDM9 associated with childhood leukemogenesis. Genome Res (2012) 1.09
Intestinal cholesterol transport proteins: an update and beyond. Curr Opin Lipidol (2007) 1.09
The Childhood Leukemia International Consortium. Cancer Epidemiol (2013) 1.09
Rationale for an international consortium to study inherited genetic susceptibility to childhood acute lymphoblastic leukemia. Haematologica (2011) 1.07
Gene expression profiles of normal proliferating and differentiating human intestinal epithelial cells: a comparison with the Caco-2 cell model. J Cell Biochem (2006) 1.05
Role of NQO1, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Int J Cancer (2002) 1.05
The peptidomimetic CXCR4 antagonist TC14012 recruits beta-arrestin to CXCR7: roles of receptor domains. J Biol Chem (2010) 1.05
Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia. Clin Cancer Res (2002) 1.05
Localization, function and regulation of the two intestinal fatty acid-binding protein types. Histochem Cell Biol (2009) 1.04
Whole-exome sequencing reveals a rapid change in the frequency of rare functional variants in a founding population of humans. PLoS Genet (2013) 1.03
Modification in oxidative stress, inflammation, and lipoprotein assembly in response to hepatocyte nuclear factor 4alpha knockdown in intestinal epithelial cells. J Biol Chem (2010) 1.02
ATF5 polymorphisms influence ATF function and response to treatment in children with childhood acute lymphoblastic leukemia. Blood (2011) 1.01
CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway. Histopathology (2012) 1.00
Genomic and genealogical investigation of the French Canadian founder population structure. Hum Genet (2011) 1.00
Anderson or chylomicron retention disease: molecular impact of five mutations in the SAR1B gene on the structure and the functionality of Sar1b protein. Mol Genet Metab (2007) 0.99
Integration of high-resolution methylome and transcriptome analyses to dissect epigenomic changes in childhood acute lymphoblastic leukemia. Cancer Res (2013) 0.99
Interaction between genetic and epigenetic variation defines gene expression patterns at the asthma-associated locus 17q12-q21 in lymphoblastoid cell lines. Hum Genet (2012) 0.98
IL-10 and TNF-alpha promoter haplotypes are associated with childhood Crohn's disease location. World J Gastroenterol (2009) 0.98
Glutathione S-transferase P1 genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukaemia. Pharmacogenetics (2002) 0.98
Subcellular proteomics of cell differentiation: quantitative analysis of the plasma membrane proteome of Caco-2 cells. Proteomics (2007) 0.97
Comparative expression analysis reveals differences in the regulation of intestinal paraoxonase family members. Int J Biochem Cell Biol (2009) 0.95
Biological role, protein expression, subcellular localization, and oxidative stress response of paraoxonase 2 in the intestine of humans and rats. Am J Physiol Gastrointest Liver Physiol (2007) 0.94
Functional promoter SNPs in cell cycle checkpoint genes. Hum Mol Genet (2005) 0.91
Characterization of the BclI polymorphism in the glucocorticoid receptor gene. Clin Chem (2003) 0.91
A detailed transcriptional map of the chromosome 12p12 tumour suppressor locus. Eur J Hum Genet (2002) 0.91
Expression of Sar1b enhances chylomicron assembly and key components of the coat protein complex II system driving vesicle budding. Arterioscler Thromb Vasc Biol (2011) 0.89
Investigational drugs targeting cardiac fibrosis. Expert Rev Cardiovasc Ther (2013) 0.89
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers. Hum Mol Genet (2011) 0.89
Association of metabolic gene polymorphisms with tobacco consumption in healthy controls. Int J Cancer (2004) 0.89
GSTT1 and CYP2E1 polymorphisms and trihalomethanes in drinking water: effect on childhood leukemia. Environ Health Perspect (2002) 0.89
Polymorphisms in genes involved in the corticosteroid response and the outcome of childhood acute lymphoblastic leukemia. Am J Pharmacogenomics (2004) 0.88
Deleted in cancer 1 (DICE1) is an essential protein controlling the topology of the inner mitochondrial membrane in C. elegans. Development (2006) 0.88
Identification of functional DNA variants in the constitutive promoter region of MDM2. Hum Genomics (2012) 0.87
Cellular aspects of intestinal lipoprotein assembly in Psammomys obesus: a model of insulin resistance and type 2 diabetes. Diabetes (2003) 0.87
Inflammatory reaction without endogenous antioxidant response in Caco-2 cells exposed to iron/ascorbate-mediated lipid peroxidation. Am J Physiol Gastrointest Liver Physiol (2003) 0.87
Genetic heterogeneity in regional populations of Quebec--parental lineages in the Gaspe Peninsula. Am J Phys Anthropol (2009) 0.85
Childhood acute lymphoblastic leukemia associated with parental alcohol consumption and polymorphisms of carcinogen-metabolizing genes. Epidemiology (2002) 0.85
DNA variants in region for noncoding interfering transcript of dihydrofolate reductase gene and outcome in childhood acute lymphoblastic leukemia. Clin Cancer Res (2009) 0.84
Apolipoprotein B antisense inhibition--update on mipomersen. Curr Pharm Des (2013) 0.84
Detection of fetomaternal genotype associations in early-onset disorders: evaluation of different methods and their application to childhood leukemia. J Biomed Biotechnol (2010) 0.84
Macrophage scavenger receptor 1 999C>T (R293X) mutation and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev (2005) 0.83
Using linkage and association to identify and model genetic effects: summary of GAW15 Group 4. Genet Epidemiol (2007) 0.82
Promoter polymorphisms in CHI3L1 are associated with asthma. J Allergy Clin Immunol (2012) 0.82
Bim polymorphisms: influence on function and response to treatment in children with acute lymphoblastic leukemia. Clin Cancer Res (2013) 0.81
Emerging anti-inflammatory therapies for atherosclerosis. Curr Pharm Des (2013) 0.81
Functional impact of sequence variation in the promoter region of TGFB1. Int J Cancer (2009) 0.80
ALG: automated genotype calling of Luminex assays. PLoS One (2011) 0.80
What is the role of erythropoietin in acute myocardial infarct? Bridging the gap between experimental models and clinical trials. Cardiovasc Drugs Ther (2013) 0.80
Power of the 2-locus TDT for testing the interaction of two susceptibility genes. BMC Proc (2007) 0.80
Identification of transcripts modulated by ETV6 expression. Br J Haematol (2006) 0.80
Patterns of variation in DNA segments upstream of transcription start sites. Hum Mutat (2007) 0.80
Polymorphisms in glucocorticoid receptor gene and the outcome of childhood acute lymphoblastic leukemia (ALL). Leuk Res (2009) 0.80
Polymorphisms of the vincristine pathway and response to treatment in children with childhood acute lymphoblastic leukemia. Pharmacogenomics (2014) 0.79
Pharmacogenetic considerations for acute lymphoblastic leukemia therapies. Expert Opin Drug Metab Toxicol (2014) 0.78
Impact of promoter polymorphisms in key regulators of the intrinsic apoptosis pathway on the outcome of childhood acute lymphoblastic leukemia. Haematologica (2013) 0.78
Functional analysis of promoter variants in KU70 and their role in cancer susceptibility. Genes Chromosomes Cancer (2012) 0.77
Hoxa9 collaborates with E2A-PBX1 in mouse B cell leukemia in association with Flt3 activation and decrease of B cell gene expression. Dev Dyn (2013) 0.77
Clinical value of drugs targeting inflammation for the management of coronary artery disease. Can J Cardiol (2012) 0.77
Regression of atherosclerosis. Curr Cardiol Rep (2012) 0.77
Role of NOS3 DNA variants in externalizing behavioral problems observed in childhood leukemia survivors. J Pediatr Hematol Oncol (2013) 0.77
Connections between ETV6-modulated genes: identification of shared features. Cancer Inform (2008) 0.76
In vivo footprinting analysis of the Glypican 3 (GPC3) promoter region in neuroblastoma cells. Biochim Biophys Acta (2007) 0.76
Variable continental distribution of polymorphisms in the coding regions of DNA-repair genes. J Hum Genet (2003) 0.76
Joint genotype inference with germline and somatic mutations. BMC Bioinformatics (2013) 0.75
Tissue distribution and regulation of the small Sar1b GTPase in mice. Cell Physiol Biochem (2014) 0.75
Analysis of the conservation of synteny between Fugu and human chromosome 12. BMC Genomics (2003) 0.75
Genetic diversity patterns in the SR-BI/II locus can be explained by a recent selective sweep. Mol Biol Evol (2004) 0.75
No evidence for association between TGFB1 promoter SNPs and the risk of childhood pre-B acute lymphoblastic leukemia among French Canadians. Haematologica (2009) 0.75
Genome-wide detection and characterization of mating asymmetry in human populations. Genet Epidemiol (2011) 0.75
[Teasing out the various factors associated with the digestive and absorptive phases of intestinal transport]. Med Sci (Paris) (2007) 0.75